how do glp 1 help lose weight GLP-1 and Loss: The Revolutionary Treatment Transforming Obesity Care in 2026 Your guide to GLP-1 side

Limitations There are significant limitations to consider

Ascletis raised $107 million in late May 2026 a placement to fund advancement of its oral GLP-1 program and to support the lead injectable depot programs through Phase 1 readouts

GLP-1 Therapy: Powerful, Popular, and Hard to Stick With Lets begin with a quick introduction to these medications

But larger, longer studies are needed to provide definitive safety confirmation

The ADA standard for the treatment of diabetes updated in 2020 indicated that patients with T2DM diagnosed with CVD or those with CVD risk factors can use GLP-1RAs and SGLT2 inhibitors with evidence of cardiovascular benefits to reduce cardiovascular risk, regardless of HbA1c levels or individualized HbA1c control objectives [189]

Concurrently with reductions in glycemia and body weight, retatrutide dose-dependently reduced systolic and diastolic blood pressure and improved lipid profiles, notably reducing non-HDL-C concentrations while decreasing triglyceride by up to 35% (Rosenstock et al